Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Zeidan AM, Pollyea DA, Borate U, Vasconcelos A, Potluri R, Rotter D, Kiendrebeogo Z, Gaugler L, Prebet T, Strocchia M, Bonifacio G, Chen C. Zeidan AM, et al. Among authors: vasconcelos a. Ann Hematol. 2023 Apr;102(4):749-754. doi: 10.1007/s00277-023-05109-5. Epub 2023 Feb 3. Ann Hematol. 2023. PMID: 36732419 Free PMC article.
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Zeidan AM, Pollyea DA, Borate U, Vasconcelos A, Potluri R, Rotter D, Kiendrebeogo Z, Gaugler L, Prebet T, Strocchia M, Bonifacio G, Chen C. Zeidan AM, et al. Among authors: vasconcelos a. Ann Hematol. 2023 Aug;102(8):2299. doi: 10.1007/s00277-023-05327-x. Ann Hematol. 2023. PMID: 37341779 Free PMC article. No abstract available.
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study.
Borate U, Seiter K, Potluri R, Mazumder D, Chevli M, Prebet T, Gaugler L, Strocchia M, Vasconcelos A, Sieluk J. Borate U, et al. Among authors: vasconcelos a. Adv Ther. 2024 Nov;41(11):4049-4064. doi: 10.1007/s12325-024-02947-1. Epub 2024 Sep 6. Adv Ther. 2024. PMID: 39240504 Free PMC article.
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance Study.
Poloni A, Raaschou-Jensen K, Mohedo FH, Paolini S, Oliva EN, Buccisano F, Vasconcelos A, Kim I, Makwana A, Bernasconi D, Rosettani B, Prebet T, Santini V. Poloni A, et al. Among authors: vasconcelos a. Clin Lymphoma Myeloma Leuk. 2024 Oct 10:S2152-2650(24)02365-6. doi: 10.1016/j.clml.2024.10.007. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39516085 Free article.
Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitis.
Sun B, Fernandes D, Kienzler AK, Paneva S, Harrison R, Ramanathan S, Harrison AL, Makuch M, Fichtner ML, Donat RF, Akdeniz D, Bayuangga H, Im MG, Williams R, Vasconcelos A, Thomsen S, Fower A, Sun R, Fox H, Mgbachi V, Davies A, Tseng M, Handel A, Kelly M, Zhao M, Bancroft J, Bashford-Rogers R, Pluvinage JV, Dandekar R, Alvarenga BD, Dustin L, Rinaldi S, Owens R, Anthony D, Bennett DL, Waters P, Davis SJ, Wilson MR, O'Connor KC, Soltys J, Carvalho AL, Irani SR. Sun B, et al. Among authors: vasconcelos a. bioRxiv [Preprint]. 2025 Jan 14:2025.01.14.631703. doi: 10.1101/2025.01.14.631703. bioRxiv. 2025. PMID: 39868113 Free PMC article. Preprint.
Critical Analysis of "Academic Indices Among Oral Pathology and Medicine Fellows in Brazil".
Braz GL, Sartori LRM, Moreno LB, van de Sande FH, Correa MB, Demarco FF, Corrêa de Oliveira LJ, Karam SA, Muniz FWMG, Goettems ML, Cenci MS, Pereira-Cenci T, Lima GDS, de Moraes RR, Soares AC, Chisini LA, Dos Santos LG, Casarin M, Boscato N, Franco MC, Schuch HS, Vasconcelos ACU, Montagner AF. Braz GL, et al. Among authors: vasconcelos acu. Oral Dis. 2025 Jan 23. doi: 10.1111/odi.15259. Online ahead of print. Oral Dis. 2025. PMID: 39846405 No abstract available.
Novel tryptophyllin peptides from Physalaemus centralis inhibit oxidative stress-induced endothelial dysfunction in rat aorta preparation.
Nogueira A, Brango-Vanegas J, Vasconcelos AG, Coleone AP, Barbosa ÉA, Moreira DC, da Silva MDG, Cabral WF, Nascimento JD, Vinícius de Sousa França J, Arcanjo DDR, Lima FCDA, Batagin-Neto A, Kückelhaus SAS, Brand GD, Plácido A, Leite JRSA. Nogueira A, et al. Among authors: vasconcelos ag. Toxicon. 2025 Jan 10;255:108234. doi: 10.1016/j.toxicon.2025.108234. Online ahead of print. Toxicon. 2025. PMID: 39800077
SARS-CoV-2 strains and clinical profiles of COVID-19 patients in a Southern Brazil hospital.
Fam BSO, Cadore NA, Sbruzzi R, Feira MF, Giudicelli GC, de Almeida LGP, Gerber AL, Guimarães APC, Vasconcelos ATR, Pereira AC, Pereira LV, Hünemeier T, Camey SA, Vianna FSL. Fam BSO, et al. Among authors: vasconcelos atr. Front Immunol. 2024 Dec 18;15:1444620. doi: 10.3389/fimmu.2024.1444620. eCollection 2024. Front Immunol. 2024. PMID: 39744633 Free PMC article.
932 results